![TNF-α and TGF-β Counter-Regulate PD-L1 Expression on Monocytes in Systemic Lupus Erythematosus | Scientific Reports TNF-α and TGF-β Counter-Regulate PD-L1 Expression on Monocytes in Systemic Lupus Erythematosus | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep00295/MediaObjects/41598_2012_Article_BFsrep00295_Fig1_HTML.jpg)
TNF-α and TGF-β Counter-Regulate PD-L1 Expression on Monocytes in Systemic Lupus Erythematosus | Scientific Reports
![Intranasal infusion of GD3 and GM1 gangliosides downregulates alpha-synuclein and controls tyrosine hydroxylase gene in a PD model mouse: Molecular Therapy Intranasal infusion of GD3 and GM1 gangliosides downregulates alpha-synuclein and controls tyrosine hydroxylase gene in a PD model mouse: Molecular Therapy](https://www.cell.com/cms/asset/70ff52d5-f6fa-4f07-90de-1eae7971b146/fx1.jpg)
Intranasal infusion of GD3 and GM1 gangliosides downregulates alpha-synuclein and controls tyrosine hydroxylase gene in a PD model mouse: Molecular Therapy
![α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas | Journal for ImmunoTherapy of α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas | Journal for ImmunoTherapy of](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40425-018-0493-9/MediaObjects/40425_2018_493_Fig6_HTML.png)